Bleichroeder LP - 19 Sep 2024 Form 4 Insider Report for DUOS TECHNOLOGIES GROUP, INC. (DUOT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Sep 2024, 18:15:33 UTC
Prior SEC filing
24 Jul 2024
Next SEC filing
19 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Michael M. Kellen, Chairman and Co-CEO of Bleichroeder, LP

Key filing fact

Bleichroeder LP filed Form 4 for DUOS TECHNOLOGIES GROUP, INC. (DUOT) on 23 Sep 2024.

Key facts

  • This page summarizes Bleichroeder LP's Form 4 filing for DUOS TECHNOLOGIES GROUP, INC. (DUOT).
  • 9 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 23 Sep 2024, 18:15.

Change

  • Previous filing in this sequence was filed on 24 Jul 2024.
  • Current net transaction value: +$899,521.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DUOT transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$899,521
Shares
+344,644
Change %
+27%
Price
$2.61
Shares after
1,627,806
Date
19 Sep 2024
Ownership
See footnote
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DUOT transaction Derivative

Warrants to Purchase Common Stock

Other

Transaction value
Shares
-300,000
Change %
-100%
Price
Shares after
0
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$3.00
Footnotes
F1, F3
DUOT transaction Derivative

Warrants to Purchase Common Stock

Other

Transaction value
Shares
-44,644
Change %
-100%
Price
Shares after
0
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
44,644
Exercise price
$0.5500
Footnotes
F1, F3
DUOT transaction Derivative

Warrants to Purchase Common Stock

Other

Transaction value
Shares
+300,000
Change %
Price
Shares after
300,000
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$2.61
Footnotes
F1, F3
DUOT transaction Derivative

Warrants to Purchase Common Stock

Other

Transaction value
Shares
+44,644
Change %
Price
Shares after
44,644
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
44,644
Exercise price
$2.61
Footnotes
F1, F3
DUOT transaction Derivative

Warrants to Purchase Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-300,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$2.61
Footnotes
F1, F3
DUOT transaction Derivative

Warrants to Purchase Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-44,644
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
44,644
Exercise price
$2.61
Footnotes
F1, F3
DUOT transaction Derivative

Series E Convertible Preferred Stock

Other

Transaction value
$12,500,000
Shares
-12,500
Change %
-100%
Price
$1000.00
Shares after
0
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
4,166,667
Exercise price
$3.00
Footnotes
F2, F3
DUOT transaction Derivative

Series E Convertible Preferred Stock

Other

Transaction value
$12,500,000
Shares
+12,500
Change %
Price
$1000.00
Shares after
12,500
Date
19 Sep 2024
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
4,789,272
Exercise price
$2.61
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On September 19, 2024, DUOS Technologies Group, Inc. (the "Issuer") and Bleichroeder LP, investment advisor to 21 April Fund, Ltd. and 21 April Fund, LP, agreed to amend (x) those certain 300,000 warrants ("2024 Warrants") to acquire Common Stock at an exercise price of $3.00 per share and (y) those certain 44,644 warrants (the "2019 Warrants") to acquire Common Stock at an exercise price of $0.55 per share (such number of shares and exercise price reflecting adjustments resulting from a 1-for-14 reverse stock split), in each case, to (i) remove a Beneficial Ownership Limitation (as defined therein) of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock upon exercise of the applicable warrants and (ii) amend the exercise price to $2.61 per share. On September 19, 2024, following the amendments of the 2024 Warrants and the 2019 Warrants, the Holders exercised the 2024 Warrants and the 2019 Warrants.

Footnote F2

On September 19, 2024, the Issuer agreed to reduce the conversion price for the Series E Convertible Preferred Stock from $3.00 to $2.61. Conversion of these shares is subject to a Beneficial Ownership Limitation of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion.

Footnote F3

This form is filed by Bleichroeder LP. The securities reported herein are directly held by 21 April Fund, Ltd. and 21 April Fund, LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .